Skip to main content
. 2019 Aug 9;18(4):4106–4113. doi: 10.3892/ol.2019.10738

Figure 2.

Figure 2.

Detection of ANKRD22 in prostate cancer. Immunohistochemical staining with monoclonal antibody (ANKRD22 clone no. 1A8) was used to detect ANKRD22 expression in prostate cancer tissues. (A) Negative control. A section of prostate cancer tissue without primary antibodies was used as an immunohistochemical negative control. (B) Detection of ANKRD22 in adjacent non-cancerous tissue. (C and D) ANKRD22 expression in the (C) cytoplasm and (D) nucleus of prostate cancer cells. Magnification, ×400. ANKRD22, ankyrin repeat domain 22.